Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Coherus Biosciences Inc’s stock clocked out at $1.57, down -3.09% from its previous closing price of $1.62. In other words, the price has decreased by -$3.09 from its previous closing price. On the day, 1.32 million shares were traded. CHRS stock price reached its highest trading level at $1.66 during the session, while it also had its lowest trading level at $1.56.
Ratios:
To gain a deeper understanding of CHRS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on August 16, 2024, Downgraded its rating to Neutral and sets its target price to $1.50 from $4 previously.
On November 17, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $11.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRS now has a Market Capitalization of 180884416 and an Enterprise Value of 353070048. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.59. Its current Enterprise Value per Revenue stands at 1.16 whereas that against EBITDA is -3.02.
Stock Price History:
Over the past 52 weeks, CHRS has reached a high of $3.13, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 28.59%, while the 200-Day Moving Average is calculated to be 3.18%.
Shares Statistics:
It appears that CHRS traded 5.05M shares on average per day over the past three months and 2363200 shares per day over the past ten days. A total of 115.21M shares are outstanding, with a floating share count of 110.57M. Insiders hold about 4.03% of the company’s shares, while institutions hold 66.10% stake in the company. Shares short for CHRS as of 1734048000 were 31073775 with a Short Ratio of 6.16, compared to 1731628800 on 33038406. Therefore, it implies a Short% of Shares Outstanding of 31073775 and a Short% of Float of 31.47.
